And potential HF biomarkers such as TNNI3, GAL-3, HSP 70, FABP3, and CKAP5 were identified in the protection of YXS against HF which facilitated the clinical location of YXS [6]. This evidence concerns the gene CKAP5 and hydrops fetalis.